Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2013-07-18 16:00:07 |
Versijas komentārs | |
Teksts |
Olainfarm will Hold
Investor Conference Webinar about Recent
Developments
AS „Olainfarm”
invites shareholders, investors, mass media representatives and
other stakeholders to join its investor conference webinar
scheduled on July 18, 2013 at 16:00 (EET).
Webinar will be
hosted by the member of the management board Salvis Lapiņš. The
presentation will be in English. During the webinar
topics in relation to AS “Olainfarm” expansion plans and analysis
of company’s recent activities and financial results will be
discussed. How to join
the webinar?
During the webinar
the enclosed presentation was presented. A/s OlainFarm
is one of the biggest pharmaceutical companies in Latvia with 40
years of experience in production of medication and chemical and
pharmaceutical products. A basic principle of company's operations
is to produce reliable and effective top quality products for
Latvia and the rest of the world. Products made by the Group are
being exported to more than 30 countries of the world, including
the Baltics, Russia, other CIS, Europe, Asia, North America and
Australia.
Information
prepared by: |
Pielikumi |